Israel
· Delayed Price · Currency is ILS · Price in ILASofWave Medical Statistics
Total Valuation
SofWave Medical has a market cap or net worth of ILS 644.98 million. The enterprise value is 570.26 million.
| Market Cap | 644.98M |
| Enterprise Value | 570.26M |
Important Dates
The next estimated earnings date is Wednesday, November 6, 2024.
| Earnings Date | Nov 6, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
SofWave Medical has 34.33 million shares outstanding. The number of shares has increased by 0.15% in one year.
| Shares Outstanding | 34.33M |
| Shares Change (YoY) | +0.15% |
| Shares Change (QoQ) | +0.41% |
| Owned by Insiders (%) | 36.70% |
| Owned by Institutions (%) | 16.60% |
| Float | 12.74M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 3.08 |
| PB Ratio | 6.84 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -36.74 |
| EV / Sales | 2.74 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -42.82 |
Financial Position
The company has a current ratio of 2.51, with a Debt / Equity ratio of 0.05.
| Current Ratio | 2.51 |
| Quick Ratio | 2.18 |
| Debt / Equity | 0.05 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.35 |
| Interest Coverage | -34.08 |
Financial Efficiency
Return on equity (ROE) is -15.83% and return on invested capital (ROIC) is -8.07%.
| Return on Equity (ROE) | -15.83% |
| Return on Assets (ROA) | -5.43% |
| Return on Capital (ROIC) | -8.07% |
| Revenue Per Employee | 1.78M |
| Profits Per Employee | -132,680 |
| Employee Count | 117 |
| Asset Turnover | 1.36 |
| Inventory Turnover | 3.00 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +88.21% in the last 52 weeks. The beta is 0.60, so SofWave Medical's price volatility has been lower than the market average.
| Beta (5Y) | 0.60 |
| 52-Week Price Change | +88.21% |
| 50-Day Moving Average | 1,740.80 |
| 200-Day Moving Average | 1,659.46 |
| Relative Strength Index (RSI) | 63.61 |
| Average Volume (20 Days) | 11,224 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SofWave Medical had revenue of ILS 208.41 million and -15.52 million in losses. Loss per share was -0.45.
| Revenue | 208.41M |
| Gross Profit | 156.08M |
| Operating Income | -13.34M |
| Pretax Income | -14.55M |
| Net Income | -15.52M |
| EBITDA | -10.03M |
| EBIT | -13.34M |
| Loss Per Share | -0.45 |
Balance Sheet
The company has 79.37 million in cash and 4.65 million in debt, giving a net cash position of 74.73 million or 2.18 per share.
| Cash & Cash Equivalents | 79.37M |
| Total Debt | 4.65M |
| Net Cash | 74.73M |
| Net Cash Per Share | 2.18 |
| Equity (Book Value) | 94.30M |
| Book Value Per Share | 2.75 |
| Working Capital | 80.89M |
Cash Flow
In the last 12 months, operating cash flow was -12.16 million and capital expenditures -1.16 million, giving a free cash flow of -13.32 million.
| Operating Cash Flow | -12.16M |
| Capital Expenditures | -1.16M |
| Free Cash Flow | -13.32M |
| FCF Per Share | -0.39 |
Margins
Gross margin is 74.89%, with operating and profit margins of -6.40% and -7.45%.
| Gross Margin | 74.89% |
| Operating Margin | -6.40% |
| Pretax Margin | -6.98% |
| Profit Margin | -7.45% |
| EBITDA Margin | -4.81% |
| EBIT Margin | -6.40% |
| FCF Margin | -6.39% |
Dividends & Yields
SofWave Medical does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.15% |
| Shareholder Yield | -0.15% |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SofWave Medical has an Altman Z-Score of 5.07.
| Altman Z-Score | 5.07 |
| Piotroski F-Score | n/a |